What are the recommended management strategies and prognosis for short rib thoracic dysplasia type 3 (biallelic DYNC2H1)?

Management and Prognosis of Short Rib Thoracic Dysplasia Type 3 (Biallelic DYNC2H1)

Immediate postnatal evaluation at a tertiary center with NICU capabilities is mandatory, as respiratory insufficiency requiring mechanical ventilation or tracheostomy occurs in 60% of cases, though overall pulmonary prognosis is better than historically reported. 1, 2

Immediate Postnatal Management

Respiratory Support

• Respiratory insufficiency is the primary determinant of early mortality, occurring in 60% of affected individuals 2
• Tracheostomy may be required in severe cases (documented in 5 of 23 living cases in one cohort) 2
• All newborns require immediate specialized respiratory assessment regardless of prenatal predictions 1

Diagnostic Confirmation

• Perform full skeletal survey immediately after birth to confirm radiographic features: narrow thorax, short ribs, shortened long bones, and trident acetabular roof 1, 2
• Molecular confirmation of biallelic DYNC2H1 variants is essential for accurate genetic counseling regarding 25% recurrence risk in future pregnancies 1

Prognostic Indicators

Antenatal Predictors of Severity

Earlier gestational presentation and more significant femur shortening/bowing predict poor postnatal outcomes 3:

• Presentation before 20 weeks correlates with severe/lethal phenotype
• Significant femur shortening (FL <5th percentile) and bowing indicate worse prognosis 3
• FL/AC ratio <0.16 suggests lethal skeletal dysplasia (91% sensitivity for lethality) 1

Phenotypic Spectrum

The condition exhibits marked variability 3, 2:

• Mild cases (44% in one series): minimal respiratory support, normal development
• Moderate cases (22%): require respiratory support but survive
• Severe/lethal cases (33%): early neonatal death from respiratory failure

Important caveat: Genotype does not reliably predict phenotype severity—clinical presentation and imaging findings are more informative 3

Long-Term Multisystem Surveillance

Renal Disease (17% of cases)

• Monitor renal function annually with creatinine, BUN, and urinalysis 2
• Renal ultrasound at diagnosis and periodically thereafter
• Progressive renal disease can develop in childhood

Hepatic Disease (22% of cases)

• Baseline and annual liver function tests 2
• Monitor for hepatic fibrosis and portal hypertension
• Abdominal ultrasound surveillance

Retinal Involvement (50% of cases >5 years)

• Retinal degeneration is more common than previously recognized 2
• Ophthalmologic examination at diagnosis, then annually starting at age 2-3 years
• Screen for progressive retinal dystrophy that can lead to vision loss

Skeletal Complications

• Orthopedic monitoring for limb deformities and joint problems
• Physical therapy to optimize mobility
• Nutritional assessment given risk of obesity in skeletal dysplasias with reduced mobility 4

Critical Management Pitfalls

1. Do not assume lethality based on prenatal diagnosis alone—postnatal evaluation may reveal milder phenotype than predicted 3, 2
2. Do not overlook extraskeletal manifestations—renal, hepatic, and retinal disease significantly impact long-term quality of life 2
3. Do not delay ophthalmologic screening—retinal involvement affects 50% by school age and requires early intervention 2
4. Do not provide false reassurance about pulmonary prognosis—while better than historically thought, 60% still require significant respiratory support 2

Genetic Counseling

• Autosomal recessive inheritance: 25% recurrence risk for each pregnancy 1
• Store fetal DNA if pregnancy is terminated to enable molecular diagnosis for future prenatal testing 1
• Preimplantation genetic diagnosis is available once biallelic pathogenic variants are confirmed 1
• Early prenatal diagnosis (as early as 12-13 weeks) is possible with detailed ultrasound in subsequent pregnancies 5, 6